IDEX Biometrics ASA
IDXAF
$0.002
$0.001100.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -79.73% | -72.47% | -53.36% | -24.74% | 1.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -79.73% | -72.47% | -53.36% | -24.74% | 1.17% |
| Cost of Revenue | -56.90% | -53.96% | -35.44% | -7.18% | 20.44% |
| Gross Profit | -462.66% | -125.82% | -111.46% | -95.49% | -72.52% |
| SG&A Expenses | -38.50% | -39.51% | -34.91% | -30.02% | -25.55% |
| Depreciation & Amortization | 53.94% | 11.54% | 70.55% | 26.76% | 20.93% |
| Other Operating Expenses | -16.64% | -21.63% | -7.02% | 1.63% | 4.06% |
| Total Operating Expenses | -26.59% | -31.96% | -24.14% | -18.37% | -12.63% |
| Operating Income | 18.40% | 25.24% | 19.54% | 17.47% | 14.43% |
| Income Before Tax | 45.32% | 44.28% | 20.02% | 21.94% | 18.51% |
| Income Tax Expenses | -700.00% | 125.76% | 119.67% | 35.48% | 58.33% |
| Earnings from Continuing Operations | 45.74% | 44.09% | 19.82% | 21.93% | 18.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.74% | 44.09% | 19.82% | 21.93% | 18.47% |
| EBIT | 18.40% | 25.24% | 19.54% | 17.47% | 14.43% |
| EBITDA | 21.47% | 28.90% | 23.48% | 19.03% | 15.76% |
| EPS Basic | 56.65% | 48.04% | 34.92% | 38.33% | 34.59% |
| Normalized Basic EPS | 50.92% | 42.69% | 35.06% | 38.22% | 34.41% |
| EPS Diluted | 58.01% | 49.73% | 32.36% | 36.54% | 33.37% |
| Normalized Diluted EPS | 51.08% | 43.03% | 35.35% | 38.54% | 34.55% |
| Average Basic Shares Outstanding | 36.13% | 9.69% | 15.40% | 18.87% | 17.85% |
| Average Diluted Shares Outstanding | 36.37% | 10.21% | 16.11% | 19.45% | 17.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |